Physicians’ Education Resource® to Present Two Satellite Symposia at the 2019 AUA Annual Meeting in Chicago.

The  two innovative live educational activities will be presented at McCormick Place West in Chicago, Illinois, on May 3 and 4, 2019 as part of the 2019 AUA Annual Meeting.

• Transforming Treatment Paradigms in Renal Cell Carcinoma: Understanding the Role of Risk Stratification and Emerging Data in the Adjuvant Setting, will be held as a breakfast symposium on Friday, May 3, from 8-9:30 a.m. in W375B on level 3. The program will be chaired by Robert A. Figlin, M.D., FACP, Steven Spielberg Family Chair in Hematology-Oncology, director of the division of hematology/oncology, deputy director of integrated oncology service line and a professor of medicine and biomedical sciences at Cedars-Sinai Medical Center. During this program, a multidisciplinary panel of renowned experts in renal cell carcinoma (RCC) will guide attendees through an in-depth, up-to-date review of risk assessment in the early-stage RCC setting; surgical standards-of-care and challenges; patient selection for adjuvant systemic therapy; evidence from clinical studies of adjuvant therapy for RCC; and overall multidisciplinary care planning. To register, click here.
• Bladder Cancer Working Group: Practical Application of Immunotherapeutic Strategies to Optimize Patient Outcomes, Next Steps to Move the Field Forward, will be held as a dinner symposium on Saturday, May 4, from 6-8 p.m. in W375A on level 3. The program will be chaired by Daniel P. Petrylak, M.D., professor of medicine and urology, co-director of the Signal Transduction Research Program, Yale Cancer Center, Yale School of Medicine. During this program, a multidisciplinary faculty of renowned experts in urology, medical oncology and immunotherapy will review practice-changing data and discuss their impact on patient care. Brief didactic presentations will be followed by real-world clinical case presentations and discussions to facilitate interpretation and application of the evidence. The faculty will also share their forward-looking perspectives on the bladder cancer treatment horizon based on recently reported and anticipated clinical trial data. To register, click here.